Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 28, 2013 | Bone Therapeutics | $10.4M Grant / Series D | — | BAMS Angel Fund, Nausicaa Ventures, Sambrinvest, SRIW |
| Mar 28, 2012 | Promethera Biosciences | $31.4M Debt / Series B | — | ATMI, Boehringer Ingelheim, Financière Spin-off Luxembourgeoise, Mitsui & Co. Global Investment, Nivelinvest, Sambrinvest, Shire, Sopartec, SRIW, Vesalius Biocapital, VIVES Louvain Technology Fund, Walloon Region |
| Sep 1, 2011 | Amakem | $25.0M Series A | Forbion | Emmanuelle Coutanceau, Chris Buyse, LRM, Kenneth W., Gaston Matthyssens |
| Nov 9, 2009 | Promethera Biosciences | $8.0M Series A | Vesalius Biocapital | Capital Croissance, LRM, Nivelinvest, Sopartec, SRIW, VIVES Louvain Technology Fund |